| Product Code: ETC12463536 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Togo continued to rely on key countries such as France, India, China, USA, and Denmark for its import shipments of Imatinib drugs. Despite a high level of market concentration indicated by the Herfindahl-Hirschman Index (HHI), the compound annual growth rate (CAGR) for the period 2020-2024 was negative at -2.47%. Furthermore, the growth rate from 2023 to 2024 decreased by -8.58%, pointing to a challenging market environment for Imatinib imports in Togo.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Togo Imatinib Drug Market Overview |
3.1 Togo Country Macro Economic Indicators |
3.2 Togo Imatinib Drug Market Revenues & Volume, 2022 & 2032F |
3.3 Togo Imatinib Drug Market - Industry Life Cycle |
3.4 Togo Imatinib Drug Market - Porter's Five Forces |
3.5 Togo Imatinib Drug Market Revenues & Volume Share, By Drug Form, 2022 & 2032F |
3.6 Togo Imatinib Drug Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 Togo Imatinib Drug Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.8 Togo Imatinib Drug Market Revenues & Volume Share, By Sales Channel, 2022 & 2032F |
3.9 Togo Imatinib Drug Market Revenues & Volume Share, By Mode of Administration, 2022 & 2032F |
4 Togo Imatinib Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Togo |
4.2.2 Growing awareness about the effectiveness of imatinib drug in treating certain types of cancer |
4.2.3 Favorable government initiatives to improve access to essential medicines |
4.3 Market Restraints |
4.3.1 High cost of imatinib drug leading to affordability issues for patients |
4.3.2 Limited healthcare infrastructure and resources in Togo affecting distribution and availability of the drug |
5 Togo Imatinib Drug Market Trends |
6 Togo Imatinib Drug Market, By Types |
6.1 Togo Imatinib Drug Market, By Drug Form |
6.1.1 Overview and Analysis |
6.1.2 Togo Imatinib Drug Market Revenues & Volume, By Drug Form, 2022 - 2032F |
6.1.3 Togo Imatinib Drug Market Revenues & Volume, By Tablets, 2022 - 2032F |
6.1.4 Togo Imatinib Drug Market Revenues & Volume, By Capsules, 2022 - 2032F |
6.1.5 Togo Imatinib Drug Market Revenues & Volume, By Powder Form, 2022 - 2032F |
6.1.6 Togo Imatinib Drug Market Revenues & Volume, By Liquid Form, 2022 - 2032F |
6.1.7 Togo Imatinib Drug Market Revenues & Volume, By Extended Release Tablets, 2022 - 2032F |
6.2 Togo Imatinib Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Togo Imatinib Drug Market Revenues & Volume, By Leukemia Treatment, 2022 - 2032F |
6.2.3 Togo Imatinib Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2022 - 2032F |
6.2.4 Togo Imatinib Drug Market Revenues & Volume, By Chronic Myeloid Leukemia, 2022 - 2032F |
6.2.5 Togo Imatinib Drug Market Revenues & Volume, By Breast Cancer Treatment, 2022 - 2032F |
6.2.6 Togo Imatinib Drug Market Revenues & Volume, By Rare Tumor Management, 2022 - 2032F |
6.3 Togo Imatinib Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Togo Imatinib Drug Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.3.3 Togo Imatinib Drug Market Revenues & Volume, By Cancer Research Centers, 2022 - 2032F |
6.3.4 Togo Imatinib Drug Market Revenues & Volume, By Specialty Clinics, 2022 - 2032F |
6.3.5 Togo Imatinib Drug Market Revenues & Volume, By Pharmaceutical Companies, 2022 - 2032F |
6.3.6 Togo Imatinib Drug Market Revenues & Volume, By Government Healthcare Units, 2022 - 2032F |
6.4 Togo Imatinib Drug Market, By Sales Channel |
6.4.1 Overview and Analysis |
6.4.2 Togo Imatinib Drug Market Revenues & Volume, By Direct Procurement, 2022 - 2032F |
6.4.3 Togo Imatinib Drug Market Revenues & Volume, By Distributors, 2022 - 2032F |
6.4.4 Togo Imatinib Drug Market Revenues & Volume, By Online Pharmacies, 2022 - 2032F |
6.4.5 Togo Imatinib Drug Market Revenues & Volume, By Hospital Pharmacies, 2022 - 2032F |
6.4.6 Togo Imatinib Drug Market Revenues & Volume, By Retail Pharmacies, 2022 - 2032F |
6.5 Togo Imatinib Drug Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 Togo Imatinib Drug Market Revenues & Volume, By Oral Administration, 2022 - 2032F |
6.5.3 Togo Imatinib Drug Market Revenues & Volume, By Injection Therapy, 2022 - 2032F |
6.5.4 Togo Imatinib Drug Market Revenues & Volume, By Infusion Therapy, 2022 - 2032F |
6.5.5 Togo Imatinib Drug Market Revenues & Volume, By Combination Therapy, 2022 - 2032F |
6.5.6 Togo Imatinib Drug Market Revenues & Volume, By Targeted Therapy, 2022 - 2032F |
7 Togo Imatinib Drug Market Import-Export Trade Statistics |
7.1 Togo Imatinib Drug Market Export to Major Countries |
7.2 Togo Imatinib Drug Market Imports from Major Countries |
8 Togo Imatinib Drug Market Key Performance Indicators |
8.1 Patient adherence rate to imatinib treatment |
8.2 Number of oncologists prescribing imatinib in Togo |
8.3 Rate of successful outcomes in cancer treatment with imatinib |
8.4 Level of government support for subsidizing imatinib drug prices |
8.5 Availability and accessibility of imatinib drug in different regions of Togo |
9 Togo Imatinib Drug Market - Opportunity Assessment |
9.1 Togo Imatinib Drug Market Opportunity Assessment, By Drug Form, 2022 & 2032F |
9.2 Togo Imatinib Drug Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 Togo Imatinib Drug Market Opportunity Assessment, By End User, 2022 & 2032F |
9.4 Togo Imatinib Drug Market Opportunity Assessment, By Sales Channel, 2022 & 2032F |
9.5 Togo Imatinib Drug Market Opportunity Assessment, By Mode of Administration, 2022 & 2032F |
10 Togo Imatinib Drug Market - Competitive Landscape |
10.1 Togo Imatinib Drug Market Revenue Share, By Companies, 2025 |
10.2 Togo Imatinib Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here